TER

+35% model: valuation sanity is 70.4/100, supported by EV/sales 15.4x, FCF yield 0.5%, gross margin 58.7%, profit margin 22.6%. 2x model: valuation-to-growth is 83.4/100 with convexity 86.9/100; that means the score is rewarding growth-adjusted asymmetry, not cheapness in isolation.

The earnings/growth score is driven by reported fundamentals, not narrative. revenue growth 87.0%, earnings growth 314.8%, gross margin 58.7%, operating margin 37.6%, profit margin 22.6%, FCF margin 7.9%. Component support: growth acceleration 98.3, survivability 81.0.

Catalyst Edge is the human-researched AI-thesis score: 79/100, with AI thesis alignment 88/100. Wafer-to-AI-data-center test bottleneck: TER sells the testers used to validate increasingly complex AI compute, memory/HBM-adjacent, and product-test devices before deployment. It is upstream infrastructure, not an AI application company. The main upside evidence: Management stated approximately 70% of Q1 revenue was tied to AI-related demand.; Record Q1 revenue/EPS and Q2 guide still above the prior-year run-rate.; Semiconductor Test is the core revenue engine and directly benefits from higher complexity AI chips and memory devices..

Technical setup comes from price action, not opinion: 20-day return 8.4%, 60-day return 22.5%, 120-day return 86.6%, 60-day relative strength vs QQQ 1.1%, 1-year max drawdown -26.7%, distance from 52-week high -11.3%, 60-day annualized volatility 83.1%. Above 50dma: True; above 200dma: True.

For June this pillar is better read as options/positioning confirmation, not social-media fluff. ATM implied volatility 77.6%, call/put OI 1.2, call/put volume 1.7, OTM call OI share 29.9%, short % float 4.5%, short ratio 1.6. Component support: options asymmetry 82.7, squeeze bonus 0.0.

Goldilox is the bull-case market-cap math: $58.6B current market cap vs $105.0B qualitative bull market cap, or about 1.79x. 35%: +35% is plausible if the Q1 record is not a pull-forward, AI-related demand remains around management's cited ~70% revenue exposure, and Q2 guidance proves conservative. The hurdle is less narrative and more whether semi-test orders sustain after a very sharp move. 2x: A 2x requires TER to be viewed as a scarce AI-test bottleneck rather than a cyclical equipment vendor: continued AI compute and memory tester demand, durable margins, and revenue run-rate expansion well beyond the Q1/Q2 guide. Possible, but it needs multiple expansion on top of already strong fundamentals. The guardrails are: Semi-test is cyclical; record quarters can mark digestion periods if customers over-order capacity.; Current quant market cap and EV/sales already embed a strong AI cycle.; AI-related revenue mix falls materially below management's cited ~70% without an offsetting new catalyst.; Q2/Q3 bookings imply Q1 was a demand pull-forward rather than a sustainable run-rate..